Form 4: PACS Group CFO Carey Hendrickson Receives RSU Grant

PACS Group CFO Carey Hendrickson was granted 48,426 restricted stock units vesting over three years.

Summary

• Carey P. Hendrickson, Chief Financial Officer of PACS Group, Inc., acquired 48,426 restricted stock units (RSUs).
• The transaction occurred on May 14, 2026.
• Each RSU entitles the holder to one share of common stock upon vesting.
• The units vest in equal annual installments over three years, contingent on continued service.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing regarding executive compensation, which is neutral in terms of immediate market impact.

Positives

• Alignment of executive interests with long-term shareholder value through equity-based compensation.

Negatives

• Potential for future shareholder dilution upon the vesting and issuance of the underlying common stock.

Risks

• Vesting is subject to the continued service of the CFO, creating potential retention risk if the executive departs before the three-year period concludes.

Future Outlook

The RSUs will vest in substantially equal annual installments on the first, second, and third anniversaries of May 14, 2026.

Industry Context

StockSavvy.ai notes that equity grants to C-suite executives are standard corporate governance practices designed to incentivize long-term performance and retention in the healthcare services sector.

Comparison to Industry Standards

• The use of three-year vesting schedules for RSU grants is consistent with standard executive compensation practices among publicly traded healthcare companies.

Stakeholder Impact

• Shareholders may experience minor dilution upon the eventual conversion of RSUs into common stock.

Next Steps

• Vesting of RSU installments on May 14, 2027, May 14, 2028, and May 14, 2029.

Key Dates

Keywords

PACS Group, PACS, Form 4, Insider Trading, CFO, Restricted Stock Units, Equity Compensation